Esomeprazole and omeprazole could boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in greater adverse effects like drowsiness, although the clinical relevance is lower in the majority of clients – observe the patient for adverse effects (e. The goal of this review was to evaluate the anxiolytic, sedative, https://medeusresearchchem.com/product-category/research-chemicals/